BIT/1AMGN (BIT/1AMGN)

Borsa Italiana: BIT/1AMGN · EUR

€359

-9.40 (-2.6%)· Recorded snapshot

Market cap	217.4B
Revenue (ttm)	33.3B
Net income (ttm)	7.7B
EPS (ttm)	€14.4
P/E (trailing)	24.9x
P/E (forward)	18.9x
Dividend	€8.50 (2.37%)
Volume	13

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 33.3B
Net income (ttm): 7.7B
EPS (ttm): €14.4
P/E (trailing): 24.9x
P/E (forward): 18.9x
Market cap: 217.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E18.9

P25 n/aP50 n/aP75 n/a

Trailing P/E24.9

P25 n/aP50 n/aP75 n/a

ROE91.5

P25 n/aP50 n/aP75 n/a

ROIC19.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BIT/1AMGN indicators

Market & fundamental data

Available fields

240

Groups with data

Currency

USD

Showing 240 of 240 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	IT
Earnings date	2026-11-03
Employees	31,500
Employees change	1,300
Employees growth	4.87%
Enterprise value	EUR 256.2B
Exchange	Borsa Italiana
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1980
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	US0311621009
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Market cap	EUR 217.4B
Next earnings date	2026-11-03
Price	EUR 358.75
Price currency	EUR
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-02
Symbol	bit/1AMGN
Website	https://www.amgen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	25.24x
Average P/E ratio (3Y)	29.44x
Average P/E ratio (5Y)	25.49x
Earnings yield	4.02%
EV/Earnings	33.48x
EV/EBIT	22.44x
EV/EBITDA	16.29x
EV/FCF	28.77x
EV/Sales	7.49x
FCF / EV yield	3.48%
FCF yield	4.1%
Forward P/E	18.89x
Graham number	69.27471
Graham upside	-80.69%
Lynch fair value	EUR 110.62
Lynch upside	-69.17%
P/(FCF - SBC) ratio	25.64x
P/(OCF - SBC) ratio	20.72x
P/B ratio	21.25x
P/E ratio	24.86x
P/FCF ratio	24.4x
P/OCF ratio	19.9x
P/S ratio	6.52x
Price/EBITDA ratio	14.38x
Sector forward P/E	16.76x
Sector P/E	20.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	33.4%
EBITDA margin	45.33%
Effective tax rate	15.01%
FCF margin	26.07%
Gross margin	71.89%
Operating margin	33.4%
Pretax margin	27%
Profit margin	22.95%
Profit per employee	EUR 242,944
Profitable quarters	9
Profitable years	23
Revenue per employee	EUR 1.1M
ROA	8.67%
ROA (5Y)	8.22%
ROCE	18.14%
ROE	91.47%
ROE (5Y)	101.82%
ROIC	19.76%
ROIC (5Y)	20.52%
SBC / revenue	1.29%
Tax / revenue	4.05%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	31.6%
EPS growth (Q)	64.91%
EPS growth (QoQ)	30.84%
EPS growth 10Y	5.12%
EPS growth 3Y	2.72%
EPS growth 5Y	10.3%
EPS growth quarters	6
EPS growth years	1
FCF growth	-4.06%
FCF growth (Q)	82.58%
FCF growth (QoQ)	136.22%
FCF growth 3Y	1.66%
FCF growth 5Y	2.72%
Gross profit growth	13.09%
Gross profit growth (Q)	12.23%
Gross profit growth 3Y	11.58%
Gross profit growth 5Y	7.36%
Net income growth	32.09%
Net income growth (Q)	65.85%
Net income growth (QoQ)	30.57%
Net income growth 3Y	3.09%
Net income growth 5Y	8.76%
Net income growth quarters	6
Net income growth years	1
OCF growth	3.87%
OCF growth (Q)	75.53%
OCF growth (QoQ)	82.82%
OCF growth 10Y	2.7%
OCF growth 3Y	4.93%
OCF growth 5Y	5.48%
Operating income growth	19.55%
Operating income growth (Q)	19.33%
Operating income growth 3Y	8.67%
Operating income growth 5Y	6.56%
Revenue growth	9.1%
Revenue growth (Q)	9.53%
Revenue growth (QoQ)	16.66%
Revenue growth 10Y	5.42%
Revenue growth 3Y	12.74%
Revenue growth 5Y	8.37%
Revenue growth quarters	13
Revenue growth years	6

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -2B
Depreciation and amortization	EUR 4.1B
EBIT	EUR 11.1B
EBITDA	EUR 15.1B
EPS	EUR 14.43
Financing cash flow	EUR -3.6B
Free cash flow	EUR 8.9B
Free cash flow minus SBC	EUR 8.5B
Gross profit	EUR 24B
Income taxes	EUR 1.4B
Investing cash flow	EUR -2.1B
Net borrowing	EUR 1.2B
Net cash flow	EUR 5.2B
Net income	EUR 7.7B
Operating cash flow minus SBC	EUR 10.5B
Operating income	EUR 11.1B
Revenue	EUR 33.3B
Stock-based compensation	EUR 430.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.89
Book value per share	EUR 18.92
Debt / EBITDA	3.27
Debt / equity	4.9
Debt / FCF	5.63
Goodwill	EUR 16.7B
Interest coverage	4.14
Long-term assets	EUR 52.4B
Long-term liabilities	EUR 50.6B
Net cash (debt)	EUR -37.9B
Net cash / market cap	-17.44%
Net debt / EBITDA	2.51
Net debt / equity	3.71
Net debt / FCF	4.26
Piotroski F-Score	8
Property, plant and equipment	EUR 7.7B
Shareholders' equity	EUR 10.2B
Tangible book value	EUR -24B
Tangible book value per share	EUR -44.47
Total assets	EUR 83.7B
Total cash	EUR 12.2B
Total debt	EUR 50.2B
Total liabilities	EUR 73.5B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.42
Current assets	EUR 31.4B
Current liabilities	EUR 22.9B
Current ratio	1.37
Inventory turnover	1.67
Net working capital	EUR 800.9M
Quick ratio	0.95
Working capital	EUR 8.3B
Working capital turnover	4.24

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.46%
Dividend growth	35.09%
Dividend growth (10Y)	12.96%
Dividend growth (3Y)	3.05%
Dividend growth (5Y)	8.12%
Dividend growth years	0
Dividend payment date	2026-09-11
Dividend payment years	8
Dividend payout frequency	Quarterly
Dividend per share	EUR 8.50
Dividend yield	2.37%
Ex-dividend date	2026-08-20
Last dividend	EUR 2.16
Payout ratio	60.45%
Shareholder yield	1.91%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 320.31
1D price change	-2.55%
1M price change	-4.05%
1M total return	-4.05%
1W price change	0.67%
1W total return	0.67%
1Y price change	39.84%
1Y return CAGR	43.74%
1Y total return	43.7%
20-day SMA	EUR 347.39
200-day SMA	EUR 314.62
3M price change	14.09%
3M total return	14.75%
50-day SMA	EUR 355.31
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 382.95
52-week high date	2026-08-25
52-week low	EUR 249.30
52-week low date	2025-10-31
6M price change	18.07%
6M total return	19.66%
All-time high	EUR 382.95
All-time high date	2026-08-25
All-time low	EUR 230.90
All-time low date	2025-09-29
Average true range (ATR)	EUR 5.69
Average volume	45.1
Change from 52-week high	-6.32%
Change from 52-week low	43.9%
Change from all-time high	-6.32%
Change from all-time low	55.37%
Change from open	-0.32%
Day's gap	-2.24%
Dollar volume	EUR 4,664
High price	EUR 359.90
Low price	EUR 358.60
Monthly RSI	58.71
Open price	EUR 359.90
Position in 52-week range	11.54%
Previous close	EUR 368.15
Price vs 150-day SMA	12%
Price vs 20-day SMA	3.27%
Price vs 200-day SMA	14.03%
Price vs 50-day SMA	0.97%
Relative volume	0.29
RSI	52.72
Sharpe ratio	1.33
Sortino ratio	2.27
Volume	13
Weekly RSI	59.52
YTD price change	28.77%
YTD total return	31.41%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	539.2M
Shares change (QoQ)	0%
Shares change (YoY)	0.46%
Shares held by insiders	0.17%
Shares held by institutions	83.8%
Short ratio	4.8 days

Deeper analysis on BIT/1AMGN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BIT/1AMGN report

Is a complete BIT/1AMGN research report available?

No complete published report is available for bit/1AMGN (BIT/1AMGN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BIT/1AMGN (BIT/1AMGN)

Price

Financial snapshot

Fair-value bridge

Latest news · BIT/1AMGN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BIT/1AMGN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BIT/1AMGN

Frequently asked questions